Once again, FDA had the privilege of attending the 2013 DiabetesMine Innovation Summit this past November. This was another great opportunity for us to share current FDA regulatory perspectives with the diabetes community and to update attendees on many of FDA’s ongoing efforts related to diabetes.

Read more